ArticleNature nanotechnology2026
Strain-isolated microneedles for ambulatory hormonal and metabolic monitoring.
Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A high-fibre diet-derived microbial polyphenol metabolite boosts T-cell stemness in cancer immunotherapy.Nature nanotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Hormones and metabolites jointly regulate physiology yet their dynamic interplay remains difficult to resolve due to the lack of technologies for continuous, multiplexed monitoring. Microneedle biosensors that access dermal interstitial fluid offer a minimally invasive approach to molecular profiling, but deployment is limited by trade-offs between fabrication scalability and precision, and by mechanical instability under skin deformation. Here we present a strain-isolated microneedle platform fabricated by combining two-photon polymerization with ultrasound-assisted moulding, enabling scalable replication of submicrometre-sharp microneedles (∼430-nm apex width) bearing hierarchical, high-surface-area microstructures. Nanostructured gold and platinum electrodes enable high-fidelity sensing at the single-needle level, providing a 4.7-fold higher peak current and a 9-fold larger electrochemical surface area, respectively. Mechanical decoupling of the sensing interface from tissue deformation preserves stable molecular access during motion. When integrated with battery-free wireless electronics and multiplexed aptameric and enzymatic sensors, the system enables continuous in vivo monitoring of serotonin and glucose for 12 h. In freely moving rats, the platform captures biomolecular dynamics associated with stress, feeding and circadian rhythms. This work establishes a mechanically robust, scalable microneedle biointerface for ambulatory molecular monitoring and context-aware assessment of physiological state.
Identifiers
42527690What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.